Skip to content
TrialScanner

NCT06747273

Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States

Phase 1TerminatedSRPTLead

Registry record

Lead sponsor
Sarepta Therapeutics, Inc.
Conditions
Limb Girdle Muscular Dystrophy; Limb Girdle Muscular Dystrophy Type 2D/R3
Primary completion
Jun 18, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06747273 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06747273: Study to Evaluate the... | TrialScanner